within Pharmacolibrary.Drugs.ATC.S;

model S02AA08
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.77,
    Cl             = 1.1277777777777778e-06,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,
    adminCount     = 1,
    Vd             = 0.0013,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.019166666666666665,
    Tlag           = 10.200000000000001
  );
  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Tetracycline</td></tr><tr><td>ATC code:</td><td>S02AA08</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>500</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>1.3</td><td>L</td></tr>
    <tr><td>clearance:</td><td>0.058</td><td>L/h/kg</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Tetracycline is a broad-spectrum antibiotic belonging to the tetracycline class, used primarily to treat a variety of bacterial infections including respiratory tract infections, urinary tract infections, skin infections such as acne, and certain sexually transmitted infections. It is generally approved for use but its clinical application has diminished in some regions due to the emergence of resistance and the availability of newer, more effective antibiotics.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after single oral dose.</p><h4>References</h4><ol><li><p>Tao, RE, et al., &amp; Feldman, SR (2023). Oral Tetracycline-Class Drugs in Dermatology: Impact of Food Intake on Absorption and Efficacy. <i>Antibiotics (Basel, Switzerland)</i> 12(7) –. DOI:<a href=\"https://doi.org/10.3390/antibiotics12071152\">10.3390/antibiotics12071152</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/37508248/\">https://pubmed.ncbi.nlm.nih.gov/37508248</a></p></li><li><p>Thompson, EJ, et al., &amp; Hornik, CP (2019). Population Pharmacokinetics of Doxycycline in Children. <i>Antimicrobial agents and chemotherapy</i> 63(12) –. DOI:<a href=\"https://doi.org/10.1128/AAC.01508-19\">10.1128/AAC.01508-19</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31548185/\">https://pubmed.ncbi.nlm.nih.gov/31548185</a></p></li><li><p>Rodvold, KA, et al., &amp; Pai, MP (2020). Omadacycline: A Review of the Clinical Pharmacokinetics and Pharmacodynamics. <i>Clinical pharmacokinetics</i> 59(4) 409–425. DOI:<a href=\"https://doi.org/10.1007/s40262-019-00843-4\">10.1007/s40262-019-00843-4</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31773505/\">https://pubmed.ncbi.nlm.nih.gov/31773505</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end S02AA08;
